Profile data is unavailable for this security.
About the company
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
- Revenue in USD (TTM)71.31m
- Net income in USD18.63m
- Incorporated2014
- Employees148.00
- LocationIRadimed Corp1025 Willa Springs Dr.WINTER SPRINGS 32708United StatesUSA
- Phone+1 (407) 677-8022
- Fax+1 (302) 636-5454
- Websitehttp://www.iradimed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surmodics Inc | 126.08m | -11.54m | 548.99m | 376.00 | -- | 4.62 | -- | 4.35 | -0.8145 | -0.8145 | 8.90 | 8.33 | 0.6922 | 2.20 | 6.03 | -- | -6.34 | -3.99 | -7.22 | -4.66 | 73.81 | 80.25 | -9.15 | -6.26 | 3.22 | -4.22 | 0.1991 | -- | -4.91 | 4.73 | -651.43 | -- | -12.34 | -- |
| Butterfly Network Inc | 76.22m | -98.51m | 581.66m | 225.00 | -- | 3.20 | -- | 7.63 | -0.4708 | -0.4708 | 0.3627 | 0.8537 | 0.2543 | 0.6416 | 4.45 | 338,755.60 | -32.87 | -- | -38.53 | -- | 29.60 | -- | -129.25 | -- | 2.95 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Quanterix Corp | 129.33m | -39.71m | 587.58m | 441.00 | -- | 1.75 | -- | 4.54 | -1.04 | -1.04 | 3.40 | 8.77 | 0.3078 | 2.37 | 4.60 | 293,265.30 | -9.45 | -15.96 | -10.30 | -17.66 | 57.42 | 52.79 | -30.71 | -53.79 | 8.99 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Varex Imaging Corp | 832.70m | 34.20m | 597.55m | 2.30k | 31.94 | 1.03 | 8.79 | 0.7176 | 0.4574 | 0.4574 | 16.46 | 14.22 | 0.6758 | 1.95 | 5.28 | 346,958.30 | 2.82 | 0.9913 | 3.33 | 1.18 | 32.16 | 31.70 | 4.17 | 1.36 | 1.89 | 2.00 | 0.4271 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Orthopediatrics Corp | 189.67m | -28.44m | 604.87m | 247.00 | -- | 1.63 | -- | 3.19 | -1.24 | -1.24 | 8.26 | 15.32 | 0.4116 | 0.4509 | 4.71 | 767,906.90 | -6.17 | -5.40 | -6.78 | -5.93 | 73.68 | 75.09 | -15.00 | -15.92 | 3.68 | -29.23 | 0.1638 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| AxoGen Inc | 180.86m | -14.31m | 612.30m | 426.00 | -- | 6.18 | -- | 3.39 | -0.3302 | -0.3302 | 4.16 | 2.26 | 0.9356 | 1.65 | 7.55 | 424,544.60 | -7.40 | -13.92 | -8.49 | -15.84 | 76.13 | 79.74 | -7.91 | -20.28 | 2.47 | -1.50 | 0.3224 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Paragon 28 Inc | 235.44m | -59.07m | 637.14m | 430.00 | -- | 4.34 | -- | 2.71 | -0.7132 | -0.7132 | 2.84 | 1.76 | 0.7703 | 0.6049 | 6.63 | 547,539.60 | -19.33 | -- | -23.48 | -- | 76.67 | -- | -25.09 | -- | 1.70 | -5.30 | 0.4295 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Mesa Laboratories Inc | 228.38m | -245.65m | 643.37m | 736.00 | -- | 3.99 | -- | 2.82 | -45.57 | -45.57 | 42.13 | 29.79 | 0.4186 | 2.74 | 5.96 | 310,298.90 | -45.02 | -9.20 | -54.70 | -9.88 | 62.47 | 60.60 | -107.56 | -28.33 | 0.5106 | 1.35 | 0.5594 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Simulations Plus Inc | 70.01m | 9.95m | 645.16m | 243.00 | 65.69 | 3.53 | 41.31 | 9.21 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
| SI-Bone Inc | 150.71m | -40.85m | 663.77m | 344.00 | -- | 4.01 | -- | 4.40 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Pacific Biosciences of California Inc | 188.87m | -400.38m | 670.42m | 796.00 | -- | 1.36 | -- | 3.55 | -1.50 | -1.50 | 0.7099 | 1.81 | 0.1125 | 2.05 | 6.69 | 237,275.10 | -23.85 | -16.19 | -26.63 | -17.81 | 26.01 | 37.35 | -211.99 | -136.21 | 7.14 | -22.46 | 0.6444 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Iradimed Corp | 71.31m | 18.63m | 726.82m | 148.00 | 39.28 | 8.71 | 37.36 | 10.19 | 1.46 | 1.46 | 5.59 | 6.59 | 0.7851 | 1.42 | 6.16 | 481,791.50 | 20.51 | 13.16 | 22.48 | 14.58 | 77.14 | 76.55 | 26.12 | 21.46 | 7.82 | 143.27 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Orthofix Medical Inc | 784.25m | -119.03m | 765.05m | 1.63k | -- | 1.45 | -- | 0.9755 | -3.14 | -3.14 | 20.72 | 13.76 | 0.8844 | 1.17 | 6.56 | 479,956.60 | -13.42 | -8.88 | -16.31 | -10.96 | 68.05 | 72.37 | -15.18 | -9.28 | 1.11 | -3.12 | 0.2069 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Figs Inc | 548.65m | 10.84m | 811.59m | 354.00 | 80.49 | 2.00 | 49.00 | 1.48 | 0.059 | 0.059 | 3.08 | 2.38 | 1.11 | 1.33 | 65.26 | 1,549,845.00 | 2.20 | -- | 2.64 | -- | 67.67 | -- | 1.97 | -- | 3.28 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Standard Biotools Inc | 155.90m | -170.60m | 830.14m | 534.00 | -- | 1.70 | -- | 5.32 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Embecta Corp | 1.12bn | 69.70m | 909.96m | 2.20k | 13.07 | -- | 8.40 | 0.8133 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
Data as of Nov 12 2024. Currency figures normalised to IRadimed Corp's reporting currency: US Dollar USD
31.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nine Ten Capital Management LLCas of 30 Jun 2024 | 877.80k | 6.93% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 560.21k | 4.42% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 556.36k | 4.39% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 447.73k | 3.53% |
| Copeland Capital Management LLCas of 30 Sep 2024 | 422.43k | 3.33% |
| Bares Capital Management, Inc.as of 30 Jun 2024 | 283.60k | 2.24% |
| Ranger Investment Management LPas of 30 Sep 2024 | 250.14k | 1.97% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 204.57k | 1.62% |
| Geode Capital Management LLCas of 30 Jun 2024 | 190.46k | 1.50% |
| RK Capital Management LLCas of 30 Jun 2024 | 170.08k | 1.34% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
